U.S. markets closed

Biostar Pharmaceuticals, Inc. (BSPM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0625-0.0855 (-57.77%)
At close: 3:59PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 11/14/2020
Current
Market Cap (intraday) 5
316.46k
Enterprise Value 3
316.46k
Trailing P/E
0.18
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.99
Price/Book (mrq)
0.01
Enterprise Value/Revenue 3
1.00
Enterprise Value/EBITDA 6
0.06

Trading Information

Stock Price History

Beta (5Y Monthly) 1.72
52-Week Change 3-50.00%
S&P500 52-Week Change 315.56%
52 Week High 30.2900
52 Week Low 30.0100
50-Day Moving Average 30.0772
200-Day Moving Average 30.0906

Share Statistics

Avg Vol (3 month) 32.54k
Avg Vol (10 day) 34.96k
Shares Outstanding 52.64M
Float 2.21M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Aug 30, 2018) 4170.44k
Short Ratio (Aug 30, 2018) 43
Short % of Float (Aug 30, 2018) 4N/A
Short % of Shares Outstanding (Aug 30, 2018) 46.46%
Shares Short (prior month Jul 30, 2018) 4246.69k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Feb 04, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2016
Most Recent Quarter (mrq)Sep 29, 2017

Profitability

Profit Margin 294.01%
Operating Margin (ttm)876.46%

Management Effectiveness

Return on Assets (ttm)4.25%
Return on Equity (ttm)2.66%

Income Statement

Revenue (ttm)317.79k
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)915.17k
EBITDA 3.89M
Net Income Avi to Common (ttm)934.35k
Diluted EPS (ttm)0.3400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)364.97k
Total Cash Per Share (mrq)0.14
Total Debt (mrq)2.43M
Total Debt/Equity (mrq)6.71
Current Ratio (mrq)0.19
Book Value Per Share (mrq)13.71

Cash Flow Statement

Operating Cash Flow (ttm)8.59M
Levered Free Cash Flow (ttm)7.47M